As of 2024-12-12, the Intrinsic Value of Quest Diagnostics Inc (DGX) is
177.93 USD. This DGX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 155.69 USD, the upside of Quest Diagnostics Inc is
14.30%.
The range of the Intrinsic Value is 138.27 - 241.04 USD
177.93 USD
Intrinsic Value
DGX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
138.27 - 241.04 |
177.93 |
14.3% |
| DCF (Growth 10y) |
163.75 - 271.04 |
205.33 |
31.9% |
| DCF (EBITDA 5y) |
167.19 - 209.19 |
196.14 |
26.0% |
| DCF (EBITDA 10y) |
185.26 - 238.72 |
217.90 |
40.0% |
| Fair Value |
91.12 - 91.12 |
91.12 |
-41.48% |
| P/E |
206.27 - 281.79 |
234.47 |
50.6% |
| EV/EBITDA |
122.56 - 219.68 |
163.63 |
5.1% |
| EPV |
121.76 - 168.38 |
145.07 |
-6.8% |
| DDM - Stable |
65.59 - 130.92 |
98.25 |
-36.9% |
| DDM - Multi |
126.48 - 194.58 |
153.17 |
-1.6% |
DGX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
17,378.12 |
| Beta |
0.17 |
| Outstanding shares (mil) |
111.62 |
| Enterprise Value (mil) |
22,865.12 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.61% |
| Cost of Debt |
4.47% |
| WACC |
6.71% |